The Effect of Panax Notoginseng Powders on Rheumatic Pain

NCT02260336 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-04-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.

Conditions

  • Rheumatic Pain

Interventions

DIETARY_SUPPLEMENT

Panax Notoginseng Powder 1g

DIETARY_SUPPLEMENT

Panax Notoginseng Powder 5g

DIETARY_SUPPLEMENT

Panax Notoginseng Powder 10g

DIETARY_SUPPLEMENT

Panax Notoginseng Powder 15g

DRUG

Celecoxib Capsule 400 mg daily

Sponsors & Collaborators

  • Chengdu PLA General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-09-30
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02260336 on ClinicalTrials.gov